Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Targeted Oncologics Will Sustain High Prices With Clear Benefits, GSK Says

Executive Summary

The high price tags of targeted therapies will continue to be supported as specific populations are identified where the oncologics can show a clear benefit, according to GlaxoSmithKline Chairman of R&D Tachi Yamada

You may also be interested in...



Genetic Testing Will Contribute To Growth In Drug Spending, Medco Predicts

The growing prevalence of genetic testing as a clinical tool will drive increased drug spending and have a significant impact on medical practice, Medco predicts in its 2006 Drug Trend Report

Genetic Testing Will Contribute To Growth In Drug Spending, Medco Predicts

The growing prevalence of genetic testing as a clinical tool will drive increased drug spending and have a significant impact on medical practice, Medco predicts in its 2006 Drug Trend Report

Biotech Drugs Will Face Competitive And Reimbursement Pressure – Analysts

Increasing competition could negatively impact market potential for biotech products, Merrill Lynch's David Munno suggested

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS046636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel